|
|
T2 Biosystems Announces Second Quarter 2022 Financial Results
|
|
|
T2 Biosystems to Explore Potential to Develop Rapid Molecular Diagnostic Test for Monkeypox Virus
|
|
|
T2 Biosystems Reports Granting of Inducement Awards
|
|
|
T2 Biosystems to Report Second Quarter 2022 Financial Results on August 15, 2022
|
|
|
T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference
|
|
|
T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel
|
|
|
T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results
|
|
|
T2 Biosystems to Appear on the Benzinga All Access Show on June 17, 2022
|
|
|
T2 Biosystems Receives Nasdaq Extension to Comply with Bid Price Rule; Company to Transfer to Nasdaq Capital Market
|
|
|
T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease
|
